See your progress as the whole story it really is download GLP Trackr on the App Store or Google Play and try it free for 7 days
Exploring the Potential of MSC Therapy in Cardiovascular Health: What Patients Should Know June 25, 2025 A New Frontier in Cardiovascular Health Cardiovascular disease remains the leading cause of death in the United States, with atherosclerosischaracterized by plaque buildup in the arteriesplaying a central role
doi: 10.3390/healthcare11172443
Nevertheless, although bariatric surgery appears to provide clinical benefits, such as significant reductions in the number of anatomical sites involved and overall disease activity, some reports have also described disease worsening after this intervention, possibly related to nutritional deficiencies or increased friction in skin folds secondary to rapid weight loss.2,811 In this context, GLP-1 receptor agonists (GLP-1 RAs), such as liraglutide and semaglutide, have demonstrated not only beneficial effects on weight reduction and other metabolic parameters, but also a capacity to lower the risk of cardiovascular events independently of weight loss, potentially through anti-inflammatory mechanisms
Figure 1 Several studies have shown that oncogenic and anti-oncogenic alterations in cancer cells may reprogram glutamine metabolism
Offered via a U.S.-based telehealth model, this program allows eligible adults to access prescription-grade GLP-1 medication without requiring insurance, while maintaining ongoing physician oversight